Suppr超能文献

刚地弓形虫:在毕赤酵母中表达的重组表面抗原2(SAG2)的血清学特征及免疫原性

Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.

作者信息

Lau Yee Ling, Fong Mun Yik

机构信息

Department of Parasitology, Faculty of Medicine, University of Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia.

出版信息

Exp Parasitol. 2008 Jul;119(3):373-8. doi: 10.1016/j.exppara.2008.03.016. Epub 2008 Apr 8.

Abstract

The full length surface antigen 2 (SAG2) gene of the protozoan parasite Toxoplasma gondii was cloned and intracellularly expressed in the Pichia pastoris expression system. The molecular weight of the expressed recombinant SAG2 (36 kDa) was much larger than the native SAG2 (22 kDa). This discrepancy in size was due to hyperglycosylation, as deglycosylation assay reduced the size of the recombinant SAG2 to 22 kDa. Despite being hyperglycosylated, the recombinant SAG2 reacted strongly with pooled anti-Toxoplasma human serum, pooled anti-Toxoplasma mouse serum and a SAG2-specific monoclonal antibody. The glycosylated recombinant SAG2 was further evaluated in Western blot and in-house enzyme-linked immunosorbent assay (ELISA) using 80 human serum samples, including confirmed early acute (IgM positive, IgG negative; n=20), acute (IgM positive, IgG positive; n=20) and chronic (IgM negative, IgG positive; n=20) toxoplasmosis patients, and toxoplasmosis negative control patients (n=20). Results of the Western blot showed that the recombinant SAG2 reacted with all 60 samples of the toxoplasmosis cases but not with the Toxoplasma-negative samples. The sensitivity of in-house ELISA was 80%, 95% and 100% for early acute, acute and chronic patients' serum samples, respectively. Vaccination study showed that serum from mice immunised with the glycosylated recombinant SAG2 reacted specifically with the native SAG2 of T. gondii. The mice were significantly protected against lethal challenge with live T. gondii RH strain tachyzoites (P<0.01) and their survival time was increased compared to controls. Therefore, the present study shows that the P. pastoris-derived recombinant SAG2 was specific and suitable for use as antigen for detecting anti-Toxoplasma IgG and IgM antibodies. The vaccination study showed that recombinant SAG2 protein was immunoprotective in mice against lethal challenge.

摘要

克隆了原生动物寄生虫刚地弓形虫的全长表面抗原2(SAG2)基因,并在毕赤酵母表达系统中进行细胞内表达。表达的重组SAG2的分子量(36 kDa)比天然SAG2(22 kDa)大得多。这种大小差异是由于高糖基化所致,因为去糖基化分析使重组SAG2的大小降至22 kDa。尽管重组SAG2发生了高糖基化,但它与合并的抗弓形虫人血清、合并的抗弓形虫小鼠血清以及一种SAG2特异性单克隆抗体发生了强烈反应。使用80份人血清样本,包括确诊的早期急性(IgM阳性,IgG阴性;n = 20)、急性(IgM阳性,IgG阳性;n = 20)和慢性(IgM阴性,IgG阳性;n = 20)弓形虫病患者以及弓形虫病阴性对照患者(n = 20),在蛋白质印迹法和内部酶联免疫吸附测定(ELISA)中对糖基化重组SAG2进行了进一步评估。蛋白质印迹法结果显示,重组SAG2与所有60份弓形虫病病例样本发生反应,但与弓形虫阴性样本无反应。内部ELISA对早期急性、急性和慢性患者血清样本的敏感性分别为80%、95%和100%。疫苗接种研究表明,用糖基化重组SAG2免疫的小鼠血清与刚地弓形虫的天然SAG2发生特异性反应。这些小鼠在受到活的刚地弓形虫RH株速殖子的致死性攻击时得到了显著保护(P<0.01),与对照组相比,它们的存活时间延长。因此,本研究表明,毕赤酵母来源的重组SAG2具有特异性,适合用作检测抗弓形虫IgG和IgM抗体的抗原。疫苗接种研究表明,重组SAG2蛋白在小鼠中对致死性攻击具有免疫保护作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验